Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Bevacizumab 11atezolizumab 8Specimen Handling 7Magnetic Resonance Spectroscopy 7Nivolumab 6durvalumab 5tremelimumab 3lenvatinib 3cabozantinib 3Ipilimumab 3ulixertinib 2tislelizumab 2relatlimab 2donafenib 2camrelizumab 2apatinib 2X-Rays 2Surgical Procedures, Operative 2Sorafenib 2Oxaliplatin 2Leucovorin 2Immunotherapy 2Fluorouracil 2Fluorodeoxyglucose F18 2trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1sonidegib 1sofosbuvir-velpatasvir drug combination 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × semaglutide × 30 days × Clear all
NCT07627191 2026-06-05

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

University of Arizona

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡